SecBot SecBot
SC 13G/A ·Filed Nov 13, 2026

FBRX

Forte Biosciences, Inc.
BEARISH
Impact 5/10
Horizondays Processed3d 13h ago SEC0001687078-26-000026
Passive stake amendment
Actionable Insight ▼ Bearish

Two passive institutional holders have fully exited within 9 days. Monitor for additional 13G filings or insider selling that could signal broader institutional disengagement. The stock's high volatility (13.7% normal daily move) amplifies the impact of ownership changes.

DirectionBearish
Confidencehigh
Horizondays

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

MPM BioImpact LLC filed an amendment to Schedule 13G reporting a complete exit from Forte Biosciences, reducing its beneficial ownership to 0 shares (0.00%) as of September 30, 2026. This follows a similar full exit by Tybourne Capital Management nine days earlier, showing a pattern of passive institutional liquidation.

Key Financial Metrics

Stake
0%
Stake Value
$0.00
Investor
MPM BioImpact LLC
Investor Type
hedge fund

Key Facts

  • MPM BioImpact LLC reduced its stake to 0 shares (0.00%) as of September 30, 2026
  • This is a complete exit from a prior beneficial ownership position
  • Filing is an amendment to Schedule 13G (passive investor status)
  • Tybourne Capital Management also exited completely 9 days prior (November 4, 2026)

Financial Impact

Complete exit by MPM BioImpact; prior stake size not stated in this filing

ownership

Risk Factors

  • Consecutive institutional exits may indicate deteriorating confidence
  • Further passive or active selling pressure from remaining holders

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
55% bullish (11 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001687078-26-000026
Document: 0001687078-26-000026-index.html0001687078-26-000026
Document: 0001687078-26-000026.txt0001687078-26-000026

Track record

15 reports on FBRX

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +39.79% at T+60 after the Apr 8, 2026 report. 4 of 7 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G/A Bearish 5/10 Entry price pending
  2. Nov 13, 20263d ago SC 13G/A Bearish 5/10 Viewing Entry price pending
  3. Nov 4, 202612d ago SC 13G/A Bearish 4/10 No price data
  4. Sep 2, 202610w ago EFFECT Bearish 7/10 Entry $76.99 settles Nov 27
  5. Sep 2, 202610w ago EFFECT Bearish 6/10 Entry $76.99 settles Nov 27
  6. Aug 27, 202611w ago 25-NSE Bearish 9/10 Entry $76.99 settles Nov 20
  7. Jul 27, 202616w ago 8-K Bullish 8/10 Entry $76.50 No price data
  8. Jun 11, 202622w ago EFFECT Bearish 6/10 Entry $17.40 No price data
  9. Jun 5, 202623w ago S-3/A Bearish 6/10 Entry $15.67 No price data
  10. Jun 2, 202623w ago S-3 Bearish 6/10 Entry $17.00 to $76.99 ▼ −352.88% −350.38% vs SPY
Showing 10 of 15

US Market Status

Market Closed · Opens in 7h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026